Founded in 2019 as a spin-off from the University of Natural Resources and Life Science Vienna, Novasign is a dynamic and forward-thinking company headquartered in the heart of Vienna, Austria. Our core mission is to revolutionize the biotech industry by leveraging cutting-edge machine learning tools, ultimately expediting bioprocess development, and shortening the time to market for both novel molecules and biosimilars.

Our team:
Intercultural and Diverse
Young and Motivated
Progressive and Open-minded

Why Novasign?
We believe that process modeling is the linchpin for accelerating biopharmaceuticals to market and reducing treatment costs. At Novasign, we're not just transforming bioprocess development but pioneering a new era of innovation, collaboration, and accessibility. Join us on this transformative journey toward a faster, more efficient biotech future.

Get Involved with the Advanced Therapies Congress


To sponsor or exhibit

Ashlea Foster
+44 208 164 3032



To speak

Ila Dickinson
+44 207 092 1150